Plus Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Plus Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Plus Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Plus Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Plus Therapeutics Inc (Plus Therapeutics) specializes in the development of targeted radiotherapeutics for central nervous system (CNS) cancers. The company uses advanced platform technologies to create novel radioactive drug formulations aimed at delivering precise and effective radiation doses directly to tumors.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Plus Therapeutics operates a state-of-the-art nanoparticle research and development (R&D) facility in San Antonio, Texas for clinical trial drug manufacturing. The company is focused on developing treatments for rare and challenging cancers with high unmet needs. Its leading investigational drug, rhenium obisbemeda, is a patented radiotherapy that targets CNS and other cancers. This drug shows promise in treating glioblastoma multiforme (GBM), leptomeningeal metastases (LM), and peritoneal cancer (PBC), with potential applications for head and neck, ovarian, breast cancers, and peritoneal metastases. The company has employed 11 research personnel as of December 31, 2024. In FY2024, the company spent US$10.6 million on its R&D activities, which grew 9.2% YoY.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer